Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - maraviroc, quantity: 150 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; calcium hydrogen phosphate; microcrystalline cellulose; magnesium stearate; colour - celsentri, in combination with other antiretroviral medicinal products, is indicated for adult patients infected with only ccr5-tropic hiv-1. the use of other active agents with celsentri is associated with a greater likelihood of treatment response.

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

viiv healthcare uk ltd - maraviroc - tablet - 150mg

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - cobicistat, quantity: 150 mg; atazanavir, quantity: 300 mg - tablet, film coated - excipient ingredients: stearic acid; croscarmellose sodium; hyprolose; crospovidone; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide red - evotaz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.

Iisrael - inglise - Ministry of Health

glaxo smith kline (israel) ltd - maraviroc - film coated tablets - maraviroc 150 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-naïve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - darunavir -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - cobicistat; tenofovir disoproxil fumarate; emtricitabine; elvitegravir -

Singapur - inglise - HSA (Health Sciences Authority)

gilead sciences singapore pte. ltd. - cobicistat on silicon dioxide 288.5mg eqv cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate 11.2mg eqv tenofovir alafenamide fumarate free base - tablet, film coated - cobicistat on silicon dioxide 288.5mg eqv cobicistat 150mg; elvitegravir 150.0mg; emtricitabine 200.0mg; tenofovir alafenamide fumarate 11.2mg eqv tenofovir alafenamide fumarate free base 10.0mg

Kanada - inglise - Health Canada

janssen inc - darunavir (darunavir ethanolate) - tablet - 150mg - darunavir (darunavir ethanolate) 150mg - hiv protease inhibitors

Kanada - inglise - Health Canada

mylan pharmaceuticals ulc - darunavir - tablet - 150mg - darunavir 150mg - hiv protease inhibitors

Euroopa Liit - inglise - myHealthbox

merck sharp & dohme limited - lamivudine, raltegravir potassium - film-coated tablets - 150 mg of lamivudine and 300 mg of raltegravir - hiv infections - antivirals for systemic use - indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infection in adults, adolescents, and children from the age of 6 years and weighing at least 30 kg without present or past evidence of viral resistance to antiviral agents of the insti (integrase strand transfer inhibitor) and nrti (nucleoside reverse transcriptase inhibitor) classes